These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22984956)

  • 1. Letter: Mucosal PCR for cytomegalovirus in refractory ulcerative colitis.
    Yoshino T; Nakase H; Matsuura M
    Aliment Pharmacol Ther; 2012 Oct; 36(8):811-2; author reply 812. PubMed ID: 22984956
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus.
    Nakase H; Yamamoto S; Matsuura M; Honzawa Y; Chiba T
    Aliment Pharmacol Ther; 2010 Aug; 32(3):510-1. PubMed ID: 20636704
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis.
    Criscuoli V; Mocciaro F; Orlando A; Rizzuto MR; Renda MC; Cottone M
    Inflamm Bowel Dis; 2009 Jun; 15(6):810-1. PubMed ID: 18839422
    [No Abstract]   [Full Text] [Related]  

  • 4. Rescue with infliximab and surgical outcomes for refractory ulcerative colitis.
    Actis GC; Pellicano R; Pinna-Pintor M; Rizzetto M
    J Am Coll Surg; 2007 Oct; 205(4):e3-4. PubMed ID: 17903716
    [No Abstract]   [Full Text] [Related]  

  • 5. Rescue therapy for steroid refractory acute severe ulcerative colitis: more choice, better outcomes?
    Gearry RB; Falvey JD
    J Gastroenterol Hepatol; 2012 Mar; 27(3):417-8. PubMed ID: 22353345
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of choice for acute severe steroid-refractory ulcerative colitis is remicade.
    Halfvarson J; Järnerot G
    Inflamm Bowel Dis; 2009 Jan; 15(1):143-5. PubMed ID: 18942766
    [No Abstract]   [Full Text] [Related]  

  • 7. Ulcerative colitis: history of a successful treatment.
    Lago P
    BioDrugs; 2010 Dec; 24 Suppl 1():34-6. PubMed ID: 21175235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomegalovirus infection in patients with ulcerative colitis].
    Baryshnikov EN; Drozdov VN; Shuliat'ev IS; Parfenov AI; Lazebnik LB
    Eksp Klin Gastroenterol; 2010; (10):25-8. PubMed ID: 21434367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
    Ainsworth MA; Brynskov J
    Ugeskr Laeger; 2007 Feb; 169(9):789-91. PubMed ID: 17355841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo in a patient receiving infliximab for refractory ulcerative colitis.
    Ismail WA; Al-Enzy SA; Alsurayei SA; Ismail AE
    Arab J Gastroenterol; 2011 Jun; 12(2):109-11. PubMed ID: 21684486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis.
    Aratari A; Margagnoni G; Koch M; Papi C
    J Crohns Colitis; 2011 Jun; 5(3):262. PubMed ID: 21575893
    [No Abstract]   [Full Text] [Related]  

  • 13. Annular purpura and ulcerative colitis: response to infliximab.
    Tan V; Bartlett M; Hosking P; Gibson PR
    Dig Liver Dis; 2007 May; 39(5):488-9. PubMed ID: 17383245
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of ulcerative colitis].
    Vavricka SR; Rogler G
    Praxis (Bern 1994); 2009 Feb; 98(4):209-12. PubMed ID: 19224489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hemolytic anemia associated with ulcerative colitis: response to infliximab.
    Leo Carnerero E; Aoufi S; Montero Cuadrado I; Herrera Martin P; Herrera Justiniano JM
    Am J Gastroenterol; 2009 Sep; 104(9):2370-1. PubMed ID: 19727107
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a role for infliximab in the treatment of severe ulcerative colitis?: the American experience.
    Sandborn WJ
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S232-3. PubMed ID: 18816658
    [No Abstract]   [Full Text] [Related]  

  • 17. [TNF-alpha antibody treatment and remission induction in ulcerative colitis: a review of a Cochrane review].
    Bjerrum JT; Munck LC; Krogh-Madsen M; Nielsen OH
    Ugeskr Laeger; 2007 Feb; 169(9):792-5. PubMed ID: 17355842
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
    Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
    Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there a role for infliximab in severe ulcerative colitis?: the European experience.
    Kohn A
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S234-5. PubMed ID: 18816780
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F; Orlando A; Scimeca D; Cottone M
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.